6533b853fe1ef96bd12ad3d2
RESEARCH PRODUCT
Estándares SEA 2019 para el control global del riesgo cardiovascular
José María MostazaXavier PintóPedro ArmarioLuis MasanaJuan F. AscasoPedro ValdivielsoTeresa Arrobas VelillaÁNgel Brea Unidad De LípidosPilar CalmarzaJesús CebolladaFernando CiveiraJosé I. Cuende MeleroMargarita Esteban SalanJacinto Fernández PardoDiego GodoyCarlos GuijarroCarlos JericóMartín LaclaustraCarlos Lahoz RalloJesús MillánJosé López MirandaOvidio Muñiz-grijalvoJosé A. PáramoVicente PascualJuan Pedro-botetPablo Pérez-martínezNúria PlanaJosé PuzoJosé T. RealEmilio RosMiguel ÁNgel Sánchez ChaparroLluis Vilasubject
Estimationmedicine.medical_specialtyVascular diseasebusiness.industryCardiovascular risk factorsNiceArteriosclerosisDisease030204 cardiovascular system & hematologymedicine.disease03 medical and health sciences0302 clinical medicinemedicinePharmacology (medical)030212 general & internal medicineCardiology and Cardiovascular MedicineIntensive care medicinebusinesscomputerRisk managementCause of deathcomputer.programming_languagedescription
One of the main goals of the Spanish Society of Arteriosclerosis is to contribute to a wider and greater knowledge of vascular disease, its prevention and treatment. Cardiovascular diseases are the leading cause of death in our country and also lead to a high degree of disability and health expenditure. Arteriosclerosis is a multifactorial disease, this is why its prevention requires a global approach that takes into account the different risk factors with which it is associated. Thus, this document summarizes the current level of knowledge and integrates recommendations and procedures to be followed for patients with established cardiovascular disease or high vascular risk. Specifically, this document reviews the main symptoms and signs to be evaluated during the clinical visit, the laboratory and imaging procedures to be routinely requested or those in special situations. It also includes the estimation of vascular risk, the diagnostic criteria of the different entities that are cardiovascular risk factors, and presents general and specific recommendations for the treatment of the different cardiovascular risk factors and their final objectives. Finally, the document includes aspects that are not often mentioned in the literature, such as the organisation of a vascular risk consultation.
year | journal | country | edition | language |
---|---|---|---|---|
2019-07-01 | Clínica e Investigación en Arteriosclerosis |